{"id":"softacort","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Softacort","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:27:31.315284+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:27:36.864611+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Softacort","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:27:37.200833+00:00"}},"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T00:08:41.085Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:27:39.497770+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05159284","phase":"PHASE4","title":"Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction","status":"RECRUITING","sponsor":"Laboratorios Thea, Spain","startDate":"2021-11-09","conditions":"Dry Eye, Meibomian Gland Dysfunction","enrollment":54},{"nctId":"NCT03907865","phase":"PHASE4","title":"Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2018-03-27","conditions":"Dry Eye","enrollment":60}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"CATARACT OPERATION"},{"count":2,"reaction":"CHROMATURIA"},{"count":2,"reaction":"CONJUNCTIVITIS"},{"count":2,"reaction":"DRUG INEFFECTIVE FOR UNAPPROVED INDICATION"},{"count":2,"reaction":"EYE IRRITATION"},{"count":2,"reaction":"INTRAOCULAR PRESSURE INCREASED"},{"count":2,"reaction":"OCULAR DISCOMFORT"},{"count":2,"reaction":"PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE"},{"count":2,"reaction":"PRODUCT PRESCRIBING ISSUE"},{"count":2,"reaction":"VISION BLURRED"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Softacort","genericName":"Softacort","companyName":"Medical University of Vienna","companyId":"medical-university-of-vienna","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:27:39.497770+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}